Literature DB >> 28410915

Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors.

Betty P Morales1, Ramon Planas2, Ramon Bartoli3, Rosa M Morillas2, Margarita Sala2, Eduard Cabré2, Irma Casas4, Helena Masnou5.   

Abstract

BACKGROUND & AIMS: The early hospital readmission of patients with decompensated cirrhosis is a current problem. A study is presented on the incidence, the impact on mortality, and the predictive factors of early hospital readmission. PATIENTS AND METHODS: On the study included 112 cirrhotic patients, discharged after some decompensation between January 2013 and May 2014. Multivariate analyses were performed to identify predictors of early readmission and mortality.
RESULTS: The early readmission rate was 29.5%. The predictive factors were male gender (OR: 2.81; 95% CI: 1.07-7.35), Model for End-Stage Liver Disease-sodium score ≥15 (OR: 3.79; 95% CI 1.48-9.64), and Charlson index ≥7 (OR: 4.34, 95% CI 1.65-11.4). This model enabled patients to be classified into low or high risk of early readmissions (13.6% vs. 52.2%). The mortality rate was significantly higher among patients with early readmission (73% vs. 35%) (p<.0001). After adjusting for the Model for End-Stage Liver Disease-sodium score, Charlson index, dependence in activities of daily living, educational status, and number of medications on discharge, the early readmission was independently associated with mortality.
CONCLUSIONS: Early hospital readmission is common, and is independently associated with mortality. Male gender, MELD-Na ≥15, and Charlson index ≥7 are predictors of early readmission. These results could be used to develop future strategies to reduce early readmission.
Copyright © 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decompensated cirrhosis; Hospital readmissions; Independent predictors; Mortality

Mesh:

Year:  2017        PMID: 28410915     DOI: 10.1016/j.dld.2017.03.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  11 in total

1.  Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.

Authors:  Jejo D Koola; Sam B Ho; Aize Cao; Guanhua Chen; Amy M Perkins; Sharon E Davis; Michael E Matheny
Journal:  Dig Dis Sci       Date:  2019-09-17       Impact factor: 3.199

2.  qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis.

Authors:  M Müller; J C Schefold; A B Leichtle; D Srivastava; G Lindner; A K Exadaktylos; C A Pfortmueller
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-21       Impact factor: 0.840

3.  Early hospital readmission and survival in patients with cirrhosis: A population-based study.

Authors:  Jeffrey M Mah; Yvonne Dewit; Patti Groome; Maya Djerboua; Christopher M Booth; Jennifer A Flemming
Journal:  Can Liver J       Date:  2019-08-27

4.  Nationwide analysis of incidence and predictors of 30-day readmissions in patients with decompensated cirrhosis.

Authors:  Mahesh Gajendran; Chandraprakash Umapathy; Abhilash Perisetti; Priyadarshini Loganathan; Alok Dwivedi; Luis A Alvarado; Marc J Zuckerman; Hemant Goyal; Sherif Elhanafi
Journal:  Frontline Gastroenterol       Date:  2021-07-02

5.  A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.

Authors:  Surender Singh; Sunil Taneja; Puneeta Tandon; Akash Bansal; Ujjwal Gorsi; Akash Roy; Arka De; Nipun Verma; Madhumita Premkumar; Ajay Duseja; Radha K Dhiman; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-07-21

6.  Hospital Readmissions in Patients with Cirrhosis: A Systematic Review.

Authors:  Eric S Orman; Marwan Ghabril; Thomas W Emmett; Naga Chalasani
Journal:  J Hosp Med       Date:  2018-04-25       Impact factor: 2.960

7.  Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database.

Authors:  Sushil Kumar Garg; Hemant Goyal; Itegbemie Obaitan; Pir Ahmad Shah; Shashank Sarvepalli; Loretta Lynn Jophlin; Dupinder Singh; Sumeet Asrani; Patrick S Kamath; Michael D Leise
Journal:  Ann Transl Med       Date:  2021-07

8.  Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis.

Authors:  Mervat Essam Behiry; Sherif Mogawer; Ahmed Yamany; Maha Rakha; Rana Awad; Nahla Emad; Yasmine Abdelfatah
Journal:  Int J Hepatol       Date:  2019-05-02

9.  Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.

Authors:  Colin Pawlowski; A J Venkatakrishnan; Eshwan Ramudu; Christian Kirkup; Arjun Puranik; Nikhil Kayal; Gabriela Berner; Akash Anand; Rakesh Barve; John C O'Horo; Andrew D Badley; Venky Soundararajan
Journal:  EClinicalMedicine       Date:  2021-03-23

10.  Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis.

Authors:  Eric S Orman; Marwan S Ghabril; Archita P Desai; Lauren Nephew; Kavish R Patidar; Sujuan Gao; Chenjia Xu; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-24       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.